Funds and ETFs ChromaDex Corporation

Equities

CDXC

US1710774076

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
3.56 USD +3.49% Intraday chart for ChromaDex Corporation +20.68% +148.95%
Chromadex Corp. is a global bioscience company. The Company is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients, commercialized as Tru Niagen, directly to consumers and distributors. The Ingredients segment develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Ingredients segment provides Niagen in ingredient form to its strategic partners. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
3.56 USD
Average target price
6.08 USD
Spread / Average Target
+70.79%
Consensus
  1. Stock Market
  2. Equities
  3. CDXC Stock
  4. Funds and ETFs ChromaDex Corporation